Cite This Page

Citation styles for FiveYear Examination of Adjuvant Dabrafenib additionally Trametinib throughout Period III Melanoma

APA style

FiveYear Examination of Adjuvant Dabrafenib additionally Trametinib throughout Period III Melanoma. (2024, January 21). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 06:26, May 5, 2024 from https://news.npo.digital/index.php?title=FiveYear_Examination_of_Adjuvant_Dabrafenib_additionally_Trametinib_throughout_Period_III_Melanoma&oldid=584420.

MLA style

"FiveYear Examination of Adjuvant Dabrafenib additionally Trametinib throughout Period III Melanoma." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 21 Jan 2024, 07:34 UTC. 5 May 2024, 06:26 <https://news.npo.digital/index.php?title=FiveYear_Examination_of_Adjuvant_Dabrafenib_additionally_Trametinib_throughout_Period_III_Melanoma&oldid=584420>.

MHRA style

OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'FiveYear Examination of Adjuvant Dabrafenib additionally Trametinib throughout Period III Melanoma', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 21 January 2024, 07:34 UTC, <https://news.npo.digital/index.php?title=FiveYear_Examination_of_Adjuvant_Dabrafenib_additionally_Trametinib_throughout_Period_III_Melanoma&oldid=584420> [accessed 5 May 2024]

Chicago style

OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "FiveYear Examination of Adjuvant Dabrafenib additionally Trametinib throughout Period III Melanoma," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=FiveYear_Examination_of_Adjuvant_Dabrafenib_additionally_Trametinib_throughout_Period_III_Melanoma&oldid=584420 (accessed May 5, 2024).

CBE/CSE style

OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. FiveYear Examination of Adjuvant Dabrafenib additionally Trametinib throughout Period III Melanoma [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 21, 07:34 UTC [cited 2024 May 5]. Available from: https://news.npo.digital/index.php?title=FiveYear_Examination_of_Adjuvant_Dabrafenib_additionally_Trametinib_throughout_Period_III_Melanoma&oldid=584420.

Bluebook style

FiveYear Examination of Adjuvant Dabrafenib additionally Trametinib throughout Period III Melanoma, https://news.npo.digital/index.php?title=FiveYear_Examination_of_Adjuvant_Dabrafenib_additionally_Trametinib_throughout_Period_III_Melanoma&oldid=584420 (last visited May 5, 2024).

BibTeX entry

 @misc{ wiki:xxx,
   author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK",
   title = "FiveYear Examination of Adjuvant Dabrafenib additionally Trametinib throughout Period III Melanoma --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ",
   year = "2024",
   url = "https://news.npo.digital/index.php?title=FiveYear_Examination_of_Adjuvant_Dabrafenib_additionally_Trametinib_throughout_Period_III_Melanoma&oldid=584420",
   note = "[Online; accessed 5-May-2024]"
 }

When using the LaTeX package url (\usepackage{url} somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred:

 @misc{ wiki:xxx,
   author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK",
   title = "FiveYear Examination of Adjuvant Dabrafenib additionally Trametinib throughout Period III Melanoma --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ",
   year = "2024",
   url = "\url{https://news.npo.digital/index.php?title=FiveYear_Examination_of_Adjuvant_Dabrafenib_additionally_Trametinib_throughout_Period_III_Melanoma&oldid=584420}",
   note = "[Online; accessed 5-May-2024]"
 }